These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17257400)

  • 1. Post-marketing assessment of content and efficacy of preservatives in artemisinin-derived antimalarial dry suspensions for paediatric use.
    Atemnkeng MA; De Cock K; Plaizier-Vercammen J
    Malar J; 2007 Jan; 6():12. PubMed ID: 17257400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay of artemether, methylparaben and propylparaben in a formulated paediatric antimalarial dry suspension.
    Atemnkeng MA; Marchand E; Plaizier-Vercammen J
    J Pharm Biomed Anal; 2007 Jan; 43(2):727-32. PubMed ID: 17074460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo.
    Atemnkeng MA; De Cock K; Plaizier-Vercammen J
    Trop Med Int Health; 2007 Jan; 12(1):68-74. PubMed ID: 17207150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
    Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
    Juma EA; Obonyo CO; Akhwale WS; Ogutu BR
    Malar J; 2008 Dec; 7():262. PubMed ID: 19102746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
    Bélard S; Ramharter M; Kurth F
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009568. PubMed ID: 33289099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial drug quality in Africa.
    Amin AA; Kokwaro GO
    J Clin Pharm Ther; 2007 Oct; 32(5):429-40. PubMed ID: 17875107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
    Hamaluba M; van der Pluijm RW; Weya J; Njuguna P; Ngama M; Kalume P; Mwambingu G; Ngetsa C; Wambua J; Boga M; Mturi N; Lal AA; Khuroo A; Taylor WRJ; Gonçalves S; Miotto O; Dhorda M; Mutinda B; Mukaka M; Waithira N; Hoglund RM; Imwong M; Tarning J; Day NPJ; White NJ; Bejon P; Dondorp AM
    Lancet Infect Dis; 2021 Oct; 21(10):1395-1406. PubMed ID: 34111412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of antimicrobial preservatives in pharmaceutical formulations using reverse-phase liquid chromatography.
    Radus TP; Gyr G
    J Pharm Sci; 1983 Mar; 72(3):221-4. PubMed ID: 6842372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study.
    Ogutu BR; Onyango KO; Koskei N; Omondi EK; Ongecha JM; Otieno GA; Obonyo C; Otieno L; Eyase F; Johnson JD; Omollo R; Perkins DJ; Akhwale W; Juma E
    Malar J; 2014 Jan; 13():33. PubMed ID: 24472156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether-lumefantrine or dihydroartemisinin-piperaquine treatment.
    Omondi P; Burugu M; Matoke-Muhia D; Too E; Nambati EA; Chege W; Musyoka KB; Thiongo K; Otinga M; Muregi F; Kimani F
    Malar J; 2019 Dec; 18(1):398. PubMed ID: 31801562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental designed optimisation and stability evaluation of dry suspensions with artemisinin derivatives for paediatric use.
    Gabriëls M; Plaizier-Vercammen J
    Int J Pharm; 2004 Sep; 283(1-2):19-34. PubMed ID: 15363498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of preservatives used in cosmetic products: salicylic acid, sodium benzoate, sodium dehydroacetate, potassium sorbate, phenoxyethanol, and parabens].
    Ikarashi Y; Uchino T; Nishimura T
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010; (128):85-90. PubMed ID: 21381401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana.
    El-Duah M; Ofori-Kwakye K
    J Vector Borne Dis; 2012 Sep; 49(3):131-9. PubMed ID: 23135006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare professionals' perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda.
    Ndagije HB; Kiguba R; Manirakiza L; Kirabira E; Sserwanga A; Nabirye L; Mukonzo J; Olsson S; Spinewine A; D'Hoore W; Speybroeck N
    Malar J; 2020 Feb; 19(1):63. PubMed ID: 32041619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorption of benzoic acid, sorbic acid, benzyl alcohol, and benzalkonium chloride by flexible tubing.
    Bahal SM; Romansky JM
    Pharm Dev Technol; 2002 Jan; 7(1):49-58. PubMed ID: 11852696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of preservative effectiveness in pharmaceutical products: the use of a wild strain of Pseudomonas cepacia.
    Zani F; Minutello A; Maggi L; Santi P; Mazza P
    J Appl Microbiol; 1997 Sep; 83(3):322-6. PubMed ID: 9351212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of artemisinin-based antimalarial drugs marketed in Nigeria.
    Izevbekhai O; Adeagbo B; Olagunju A; Bolaji O
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):90-96. PubMed ID: 28460126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.